Incidence and Sex-Based Comparison of Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement

J Soc Cardiovasc Angiogr Interv. 2025 May 1;4(7):103621. doi: 10.1016/j.jscai.2025.103621. eCollection 2025 Jul.

Abstract

Background: Prosthesis-patient mismatch (PPM) remains a topic of controversy in patients undergoing transcatheter aortic valve replacement (TAVR), particularly among women with smaller annuli. Although self-expanding valves (SEV) appear to provide superior hemodynamic performance than balloon-expandable valves, the impact of PPM severity on long-term survival, particularly regarding sex-specific differences, remains inadequately characterized.

Methods: This retrospective cohort study analyzed 3016 patients (1338 women) who underwent native valve TAVR from 2012 to 2021. Patients were stratified by sex, valve type (balloon-expandable valve vs SEV), and PPM predicted (PPMP) and measured (PPMM) severity as defined by the Valve Academic Research Consortium. The primary outcome was all-cause mortality at 5 years, with secondary outcomes including PPM incidence, severity, and residual transvalvular gradients.

Results: Women exhibited higher rates of severe PPMP (1.7% vs 0.1%; P < .001) and severe PPMM (7.3% vs 5.4%; P = .033). Notably, neither moderate nor severe PPMP or PPMM adversely affected 5-year survival in women (severe PPMP hazard ratio [HR], 1.24; P = .709; severe PPMM HR, 1.35; P = .168). SEVs were associated with lower overall PPMP (12.8% vs 31.8%) and PPMM (16.1% vs 31.1%) and superior hemodynamics. Although SEVs demonstrated a nonsignificant lower unadjusted survival (44.4% vs 38.0%; P = .286), 5-year survival was similar within PPM strata after risk adjustment (overall PPMP HR, 0.51; P = .510; overall PPMM HR, 0.77; P = .412).

Conclusions: Despite a higher incidence and severity of both PPMP and PPMM, women did not experience decreased long-term survival after TAVR. Additionally, there was no risk-adjusted survival difference between valve types, emphasizing the need for individualized prosthesis selection and lifetime valve management considerations.

Keywords: balloon-expandable valves; prosthesis-patient mismatch; self-expanding valves; sex differences; transcatheter aortic valve replacement.